NEXTGENPCR: 30 cycli, 3 temperatures, less than 2 minutes

Archives

Author's Posts

Base location: Netherlands (preferred)

Molecular Biology Systems (MBS) have developed an industry-leading PCR platform focused on time-to-result. We are seeking candidates with sales management and distribution experience to manage the company’s distributor network in Europe/Middle East/Asia as we grow. This is a fantastic opportunity with enormous potential!

Responsibilities:

  • Manage international distribution sales network, review territories, set sales forecasts and ensure revenue targets are achieved.
  • Prioritise markets and determine market entry strategies for new regions.
  • Establish and lead regular meetings and conference calls with distributors.
  • Train distributors to ensure continual improvement in product knowledge and customer service. Prepare monthly and quarterly reports, and sales forecasts.
  • Develop and maintain relationships with key customers in each distributor territory.
  • Manage and attend trade-show exhibitions.
  • Support voice-of-customer research.
  • Significant international travel required.

Qualifications:

  • Degree or Training in Molecular Biology (or similar); PCR/qPCR experience preferred.
  • 3 years life science sales/sales management experience required.
  • International distribution experience preferred.
  • Strong communication and presentation skills; able to motivate distributor teams and effectively engage with customers.
  • Ability to develop training programs for distributors.
  • Excellent time management and organisational skills.

Offered:

  • Good compensation, including a bonus scheme.
  • Room for personal growth.
  • Pleasant working environment.
  • The opportunity to grow in international business.

Send your email to:

gertdevos@mbspcr.com

Please follow and like us:
error

May 31st, 10:00 am ET

Until now PCR instruments have relied on Peltier elements to heat and cool an aluminum or silver block, accommodating 96 or 384 polypropylene tubes, holding PCR-mixes. Using this technology PCR times, for 30 cycle, 3-temperature reactions, are usually between 50 and 150 minutes. Now, NEXTGENPCR is redefining fast. The thermocycler introduces a new way to heat and cool the samples instantly, with virtually no ramp rates, losing no time getting the samples to the desired temperature.

The user can go from melting to annealing in less than 0.1 second. For a 100 base pair fragment, total reaction time is as low as 2 minutes, with 700 base pairs being amplified in 10 minutes. Adding NEXTGENPCR into workflows results in higher sample throughput. Using optimized applications, more than 10 full plate experiments per hour become possible. Operated at capacity this would mean 80, 384-well plates per day, resulting in more than 30,000 datapoints per day; far beyond the capabilities of common thermocyclers.

During the presentation, Gert will focus on the technology behind NEXTGENPCR. Special attention will be paid to publications detailing 2 minute PCR data and how NEXTGENPCR amplified all 29 fragments of the BRCA1 gene in less than 10 minutes for subsequent Sanger sequencing.

 

REGISTER NOW

The webinar is sponsored by: our distributor in the US and Canada: Canon Biomedical

 

 

Please follow and like us:
error

Partnership rapidly provides NEXTGENPCR to US and Canadian customers

Amsterdam, April 23rd 2018:

Dutch biotechnology company Molecular Biology Systems (MBS) today announced it will launch its revolutionary NEXTGENPCR thermal cycler in the US and Canada through Canon BioMedical, Inc., a wholly owned subsidiary of Canon U.S.A., Inc. focused on empowering the biomedical research and healthcare communities by developing, manufacturing, and marketing innovative technologies and solutions.

According to the latest surveys, the global life sciences instrumentation market continues to grow at a CAGR of 8.2% and is predicted to be worth $85.1 billion by 2022. The US and Canada account for the largest share, fueled by a rapid adoption rate of novel technologies, the large number of life science research studies conducted in the region, and increased funding for life science research activities.

Read the whole article:  MBS Inks Deal with Canon BioMedical

Please follow and like us:
error

Following a successful debut last year, we will again be present at the Festival of Genomics, London to be held January 30-31 in the ExCeL Centre.

Come at visit us on stand D5 and see the latest version of our super fast NEXTGENPCR thermal cycler which slashes PCR reaction times to between 2 and 10 minutes.

Now available across Europe through our growing network of distributors, we appear to have struck a chord with you and your fellow scientists looking to save precious time on this tedious yet essential task.

Please follow and like us:
error

Strong demand predicted across all life science markets

Dutch biotechnology company Molecular Biology Systems(MBS) today announced it will launch its revolutionary NEXTGENPCR thermal cycler through AMPLITECH, an independent commercial organization offering innovative solutions to the public and private in vitro diagnostic testing market, including cytogenetics, molecular genetics, and pathology labs, in France, Belgium, Luxembourg, and Switzerland.

 

Read the whole article: MBS Selects CAMLAB To Launch NEXTGENPCR In UK At Lab Innovations

Please follow and like us:
error

Strong demand predicted across all life science markets

Dutch biotechnology company Molecular Biology Systems(MBS) today announced will launch its revolutionary NEXTGENPCR thermal cycler through CAMLAB, the UK’s leading independent scientific instrumentation distributor. First showing will be at the upcoming Lab Innovations at Birmingham NEC, Nov 1-2. The UK remains a key market for the life sciences, with continuing public and private infrastructure investment – including the recently announced £146 million from the Industrial Strategy Challenge Fund.

 

Read the whole article: MBS Selects CAMLAB To Launch NEXTGENPCR In UK At Lab Innovations

Please follow and like us:
error

New deals in China, Israel, Russia, Benelux, Spain, Czech Republic and UK reflect strong demand for ultra-fast new thermal cycler

Amsterdam, September 19, 2017: Dutch biotechnology company Molecular Biology Systems(MBS) continues to build its global sales network with the announcement today of new distributors for revolutionary NEXTGENPCR thermal cycler in China – PreMed Lab; Israel – Pronto Diagnostics; Czech Republic – YBUX; Albiogen – Russian Federation; Isogen – Benelux, Spain and CAMLAB – UK.

Read the whole article: MBS – Distrib Network Ver 1. 19-spn.pdf

 

Please follow and like us:
error

Superfast cycler stuns genomics community with sub-2 minute protocols

Amsterdam, July, 2017: Dutch biotechnology company Molecular Biology Systems(MBS) today reported major interest for its revolutionary NEXTGENPCR thermal cycler following the appearance of the first production models at the recent ESGH and LABVOLUTION meetings.

Described as the first real advance in thermal cycling for 15 years, the NEXTGENPCR dramatically slashes current time-consuming DNA amplification from hours to minutes.

Read the whole article: MBS-Post ESHG_LABVOLUTION Ver 1.5.09

Please follow and like us:
error

Demand grows for superfast cycler after LABVOLUTION and ESHG showing

Amsterdam, July, 2017: Dutch biotechnology company Molecular Biology Systems(MBS) today announced it has signed an exclusive distributor agreement for its revolutionary NEXTGENPCR thermal cycler with Isogen Life Sciences. This follows highly successful showings of the first production models at the recent ESHG and LABVOLUTIONS meetings. The distributorship covers both Benelux where Isogen has facilities in De Meern (Netherlands) and Temse (Belgium and Luxembourg) and Spain, which is managed from Barcelona.

Read the whole article: MBS-ISOGEN Ver 1.5.09

Please follow and like us:
error

Be first to see the production model NEXTGENPCR at ESHG 27th to 29th May 2017

A year on from our debut appearance in Barcelona, MBS will again be exhibiting at ESGG. This time visitors to Copenhagen, May 27-30, will be able to see the production version of our NEXTGENPCR thermal cycler. Interest is sure to be high, so if you would like at in-depth presentation please email us in advance to fix a time. Otherwise look forward to seeing you on Booth C3-580

Please follow and like us:
error